ABVC BioPharma, Inc. Temporary Equity, Aggregate Amount of Redemption Requirement
ABVC BioPharma, Inc. (ABVC) had Temporary Equity, Aggregate Amount of Redemption Requirement of $610.54 thousand as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement · last filed 2023-11-15
- 2023-06-30: Temporary Equity, Aggregate Amount of Redemption Requirement $610.54K.
- 2023-03-31: Temporary Equity, Aggregate Amount of Redemption Requirement $623.86K.
- 2022-12-31: Temporary Equity, Aggregate Amount of Redemption Requirement $618.15K.
- 2022-09-30: Temporary Equity, Aggregate Amount of Redemption Requirement $599.13K.
| Period end | Temporary Equity, Aggregate Amount of Redemption Requirement | Temporary Equity, Aggregate Amount of Redemption Requirement as first filed |
|---|---|---|
| 2023-06-30 | $610.54K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $623.86K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $618.15K 10-Q · filed 2023-11-15 | |
| 2022-09-30 | $599.13K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $639.07K 10-Q · filed 2022-08-15 | |
| 2021-12-31 | $618.15K 10-K · filed 2023-03-31 | $684.72K 10-Q · filed 2022-08-15 |